Innovation is at the core of the technology behind ComboCap dual delivery health products. Combinations that were previously out of reach, are now a reality. Increased bioavailability, better medication adherence and the enhanced efficacy of combination therapies are a few of the expected outcomes and consumer benefits, all grounded in scientific research.
NEVER UNDERESTIMATE THE POWER OF BEAUTY
EXTEND THE LIFE CYCLE OF A TRUSTED BRAND
CLINICALLY PROVEN – STRONGER TOGETHER
Combining existing products with complementary ingredients allows for a broader therapeutic and nutritional offering. This means greater potential for better long term results, reduced dosages and a more balanced product. ComboCap® marks the emergence of a new and exciting product category that is eye-catching and engaging – an immediate differentiator in a mature and saturated industry.
Every ComboCap product is visually appealing, and with the right packaging, will be a striking focal point on a crowded retail shelf. It projects an innovative take on a familiar looking product with its recognizable shape and dual compartment design. Its benefits are easy to market and understand, presenting itself as the intuitive preference for consumers.
Existing products can be reformulated using liquids to allow for a product line extension when close to the patent expiration date. ComboCap may also provide an opportunity for improved absorption and bioavailability when compared to tablets. In turn, due to less complex formulation and development processes, an extended marketing period may be possible.
Modern developments in molecular biology and our scientific understanding of the development of disease has served as a catalyst for more innovative, targeted therapies. Combination therapies have been around since the invention of the multivitamin but have never been thought of as a category all its own. As interventions in which more than one therapy is administered to the patient at the same time, begin to show promising results, ComboCap® will become the iconic product for an increasingly well-defined stand-alone category. We anticipate that some of these combination therapies could be formulated as dual dose medicines, or combinations of food derivatives and prescription medications. The ComboCap technology makes it possible to create a single product that contains several ingredients, including prescription drugs, shown to be more effective when taken together, but require separation prior to ingestion.
With maximum dosages, resistances and other factors impacting treatments, combination therapies may bring about measured increases in response rates.
Clinical trials to test the efficacy and safety of specific combination therapies are necessary to ensure that the combined effects are not hazardous and that the two methods interact with each other effectively. These trials also play an important role in formulating treatment methods that may require harmful levels of toxicity, as smaller doses can be used for curing disease or bringing about remission.